- Home
- EPOW vs CLNN Comparison
EPOW vs CLNN Comparison
Compare EPOW & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- CLNN
- Stock Information
- Founded
- EPOW 2014
- CLNN 2012
- Country
- EPOW China
- CLNN United States
- Employees
- EPOW N/A
- CLNN N/A
- Industry
- EPOW Business Services
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- EPOW Consumer Discretionary
- CLNN Health Care
- Exchange
- EPOW Nasdaq
- CLNN Nasdaq
- Market Cap
- EPOW 27.0M
- CLNN 23.1M
- IPO Year
- EPOW 2021
- CLNN N/A
- Fundamental
- Price
- EPOW $0.94
- CLNN $3.92
- Analyst Decision
- EPOW
- CLNN Strong Buy
- Analyst Count
- EPOW 0
- CLNN 5
- Target Price
- EPOW N/A
- CLNN $40.00
- AVG Volume (30 Days)
- EPOW 14.4K
- CLNN 140.0K
- Earning Date
- EPOW 07-07-2025
- CLNN 08-06-2025
- Dividend Yield
- EPOW N/A
- CLNN N/A
- EPS Growth
- EPOW N/A
- CLNN N/A
- EPS
- EPOW N/A
- CLNN N/A
- Revenue
- EPOW $64,997,741.00
- CLNN $350,000.00
- Revenue This Year
- EPOW N/A
- CLNN N/A
- Revenue Next Year
- EPOW N/A
- CLNN $1,753.57
- P/E Ratio
- EPOW N/A
- CLNN N/A
- Revenue Growth
- EPOW 44.28
- CLNN N/A
- 52 Week Low
- EPOW $0.55
- CLNN $2.28
- 52 Week High
- EPOW $1.36
- CLNN $7.59
- Technical
- Relative Strength Index (RSI)
- EPOW 51.42
- CLNN 52.37
- Support Level
- EPOW $0.91
- CLNN $4.12
- Resistance Level
- EPOW $0.96
- CLNN $4.40
- Average True Range (ATR)
- EPOW 0.04
- CLNN 0.26
- MACD
- EPOW 0.00
- CLNN -0.06
- Stochastic Oscillator
- EPOW 60.00
- CLNN 7.89
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is into the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.